REN and cardiomyopathy: UA Tech Launch, along with the authors, have filed USA patents application related to (1) the methods of personalized treatment for cardiomyopathy and heart failure and other related diseases by measuring renin activity, pro-renin and (pro)renin receptor levels in blood (Pub.